Print

Activplant Corporation Announces Global Agreement with GlaxoSmithKline (GSK)  
2/10/2009 10:51:26 AM

Industry Leaders Team up to Drive Performance Improvements World Wide

LONDON, Ontario, Feb. 10 /PRNewswire/ -- Activplant Corporation (www.activplant.com) announced today that GlaxoSmithKline PLC (GSK) has signed a global framework agreement naming Activplant as a recommended business intelligence solution for their world wide manufacturing sites.

The agreement comes after a successful implementation where GSK experienced the ease of use that empowers operators, engineers and management to positively affect their OEE, and consequently, their production costs. Activplant's Throughput Analyzer software product is currently implemented within key GSK facilities in North America and the UK.

"Once we saw how quickly Activplant's Throughput Analyzer could be implemented and drive results in our facility in North Carolina, we felt that it made sense to negotiate a global framework agreement to reduce complexity where our facilities wish to consider implementing OEE projects," said Julian Ward, GSK's application champion. "Over the next 3 months our aim is to achieve a 5% improvement in OEE on the lines running Throughput Analyzer and, with what we have seen to date, we feel we'll improve throughput and efficiencies across all lines where we implement the solution."

"Today's global manufacturing landscape is becoming increasingly competitive and complex. It is critical for manufacturers to arm themselves with real-time operations intelligence facilitating improved decision making and driving a reduction in operating costs," states Activplant President, Drew Forret. "We are thrilled to add GSK as a valued business partner. They are a recognized leader in the Pharmaceutical and Consumer Healthcare sectors, both of which have played an important role in Activplant's continued growth strategy."

Activplant Corporation- an enterprise manufacturing intelligence market leader, Activplant's solutions have set the standard in operational excellence within the world's largest and most admired manufacturers. Aimed at high-volume, high-automation plants, Activplant's technology consolidates plant floor data into relevant real-time and historical intelligence, enabling productivity gains through better decision making. With Activplant solutions, manufacturers can focus on the key issues in their facilities and thereby improve throughput, product quality, and operating margins. Activplant is a privately held company based in London, Ontario. For more information please visit www.activplant.com .

GlaxoSmithKline- one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com

CONTACT: Kathryn Clark, Activplant Corporation, +1-877-809-6444 ex. 378,
kclark@activplant.com

Web site: http://www.activplant.com/
http://www.gsk.com/


//-->